APA (7th ed.) Citation

RS, T., C, R., EL, V., DD, N., S, S., A, S., . . . R, S. (2026). Addition of immune checkpoint inhibitors to intravesical BCG for high-risk BCG-naïve non-muscle invasive bladder cancer: Systematic review and meta-analysis. BJUI compass, 7(4), e70194. https://doi.org/10.1002/bco2.70194

Chicago Style (17th ed.) Citation

RS, Titus, et al. "Addition of Immune Checkpoint Inhibitors to Intravesical BCG for High-risk BCG-naïve Non-muscle Invasive Bladder Cancer: Systematic Review and Meta-analysis." BJUI Compass 7, no. 4 (2026): e70194. https://doi.org/10.1002/bco2.70194.

MLA (9th ed.) Citation

RS, Titus, et al. "Addition of Immune Checkpoint Inhibitors to Intravesical BCG for High-risk BCG-naïve Non-muscle Invasive Bladder Cancer: Systematic Review and Meta-analysis." BJUI Compass, vol. 7, no. 4, 2026, p. e70194, https://doi.org/10.1002/bco2.70194.